View in EDS

Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.
Authors: Naderi Z; Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, Australia.; School of Medicine, College of Health, Adelaide University, Adelaide, Australia., Sadras T; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Branford S; School of Medicine, College of Health, Adelaide University, Adelaide, Australia.; Department of Haematology and Bone Marrow Transplantation, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia., Shanmuganathan N; School of Medicine, College of Health, Adelaide University, Adelaide, Australia. Naranie.shanmuganathan@sa.gov.au.; Centre for Cancer Biology, SA Pathology, Adelaide, Australia. Naranie.shanmuganathan@sa.gov.au., Pagani IS; Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, Australia.; School of Medicine, College of Health, Adelaide University, Adelaide, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.
Source: Current hematologic malignancy reports [Curr Hematol Malig Rep] 2026 Apr 25; Vol. 21 (1). Date of Electronic Publication: 2026 Apr 25.
Publication Type: Journal Article; Review
Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-822X (Electronic) Linking ISSN: 15588211 NLM ISO Abbreviation: Curr Hematol Malig Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42033491
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Naderi+Z%22">Naderi Z</searchLink>; Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, Australia.; School of Medicine, College of Health, Adelaide University, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Sadras+T%22">Sadras T</searchLink>; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Branford+S%22">Branford S</searchLink>; School of Medicine, College of Health, Adelaide University, Adelaide, Australia.; Department of Haematology and Bone Marrow Transplantation, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Shanmuganathan+N%22">Shanmuganathan N</searchLink>; School of Medicine, College of Health, Adelaide University, Adelaide, Australia. Naranie.shanmuganathan@sa.gov.au.; Centre for Cancer Biology, SA Pathology, Adelaide, Australia. Naranie.shanmuganathan@sa.gov.au.<br /><searchLink fieldCode="AU" term="%22Pagani+IS%22">Pagani IS</searchLink>; Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute, Adelaide, Australia.; School of Medicine, College of Health, Adelaide University, Adelaide, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101262565%22">Current hematologic malignancy reports</searchLink> [Curr Hematol Malig Rep] 2026 Apr 25; Vol. 21 (1). <i>Date of Electronic Publication: </i>2026 Apr 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Current+Science%22">Current Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101262565 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-822X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215588211%22">15588211 </searchLink><i>NLM ISO Abbreviation: </i>Curr Hematol Malig Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42033491
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11899-026-00778-1
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Naderi Z
      – PersonEntity:
          Name:
            NameFull: Sadras T
      – PersonEntity:
          Name:
            NameFull: Branford S
      – PersonEntity:
          Name:
            NameFull: Shanmuganathan N
      – PersonEntity:
          Name:
            NameFull: Pagani IS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 04
              Text: 2026 Apr 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1558-822X
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Current hematologic malignancy reports
              Type: main
ResultId 1